Skip to Content

Removab

Licence status
Withdrawn: 02/06/2017
Active substances
Catumaxomab
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/09/512/002
Licence holder
Fresenius Biotech GmbH

Licence information

ATC code
L01XC Monoclonal antibodies, L01XC09 catumaxomab
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/04/2009

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie